Vaccine Injury Table

Bookmark and Share

 

Vaccine

Illness, disability, injury or condition covered

Time period for first symptom or manifestation of onset or of significant aggravation after vaccine administration

I. Vaccines containing tetanus toxoid (e.g., DTaP, DTP, DT, Td, or TT) A. Anaphylaxis or anaphylactic shock 4 hours.
    B. Brachial Neuritis 2-28 days.
    C. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed Not applicable.
II. Vaccines containing whole cell pertussis bacteria, extracted or partial cell pertussis bacteria, or specific pertussis antigen(s) (e.g., DTP, DTaP, P, DTP-Hib) A. Anaphylaxis or anaphylactic shock 4 hours.
    B. Encephalopathy (or encephalitis) 72 hours.
    C. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed Not applicable.
III. Measles, mumps, and rubella vaccine or any of its components (e.g., MMR, MR, M, R) A. Anaphylaxis or anaphylactic shock 4 hours.
    B. Encephalopathy (or encephalitis) 5-15 days (not less than 5 days and not more than 15 days).
    C. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed Not applicable.
IV. Vaccines containing rubella virus (e.g., MMR, MR, R) A. Chronic arthritis 7-42 days.
    B. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed Not applicable.
V. Vaccines containing measles virus (e.g., MMR, MR, M) A. Thrombocytopenic purpura 7-30 days.
    B. Vaccine-Strain Measles Viral Infection in an immunodeficient recipient 6 months.
    C. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed Not applicable.
VI. Vaccines containing polio live virus (OPV) A. Paralytic Polio  
    —in a non-immunodeficient recipient 30 days.
    —in an immunodeficient recipient 6 months.
    —in a vaccine associated community case Not applicable.
    B. Vaccine-Strain Polio Viral Infection  
    —in a non-immunodeficient recipient 30 days.
    —in an immunodeficient recipient 6 months.
    —in a vaccine associated community case Not applicable.
    C. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed Not applicable.
VII. Vaccines containing polio inactivated virus (e.g., IPV) A. Anaphylaxis or anaphylactic shock 4 hours
    B. Any acute complication or sequela (including death of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed. Not applicable.
VIII. Hepatitis B. vaccines A. Anaphylaxis or anaphylactic shock 4 hours.
    B. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed Not applicable.
IX. Hemophilus influenzae type b polysaccharide conjugate vaccines No Condition Specified Not applicable.
X. Varicella vaccine No Condition Specified Not applicable.
XI. Rotavirus vaccine A. Intussusception  1-21 days
B. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed. Not applicable
XII. Pneumococcal conjugate vaccines No Condition Specified Not applicable.
XIII. Hepatitis A vaccines No Condition Specified Not applicable.
XIV. Trivalent influenza vaccines No Condition Specified Not applicable.
XV. Meningococcal vaccines No Condition Specified Not applicable.
XVI. Human papillomavirus (HPV) vaccines No Condition Specified Not applicable.
XVII. Any new vaccine recommended by the Centers for Disease Control and Prevention for routine administration to children, after publication by the Secretary of a notice of coverage* No Condition Specified Not applicable.

*HRSA note: Now includes all vaccines against seasonal influenza (except trivalent influenza vaccines, which are already covered), effective November 12, 2013.

TEXT US NOW css.php